Mr. Speaker, the hon. member provides some constructive points. On that issue, I have heard from this side of the House, short of what we hear in Romanow, that prevention to the extent that we can will have to become an increasingly important part of our discharge of the Canada Health Act, certainly as far as health care is concerned. However we have to recognize that we have an aging population.
We have to ensure that, while there are private companies involved in the delivery of a universal health care system, we do not invite a NAFTA challenge on the question of investment. We do not want to put ourselves in the position where we break away from the five principles, but we have to recognize the real context of what is causing and undermining our health care system. One of the most important ones, which has been identified by virtually every study in Canada over the past year, has been the dramatic and unacceptable rise in prescription drug prices because we have literally given away the farm and in turn received very little investment and a whole lot of debt.